|
US8968721B2
(en)
|
2005-12-28 |
2015-03-03 |
Advanced Bionutrition Corporation |
Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
|
WO2007079147A2
(en)
|
2005-12-28 |
2007-07-12 |
Advanced Bionutrition Corporation |
A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
|
JP5285617B2
(ja)
|
2006-12-18 |
2013-09-11 |
アドバンスド バイオニュートリション コーポレーション |
生きたプロバイオティクスを含む乾燥食物製品
|
|
AU2009295623A1
(en)
|
2008-09-24 |
2010-04-01 |
Stabilitech Ltd |
Method for preserving polypeptides using a sugar and polyethyleneimine
|
|
EP3266448B1
(en)
|
2009-03-27 |
2022-02-16 |
Intervet International B.V. |
Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
|
|
JP5804453B2
(ja)
*
|
2009-05-14 |
2015-11-04 |
国立大学法人 東京大学 |
結晶性ポリオール微粒子及びその調製方法
|
|
SG176253A1
(en)
|
2009-05-26 |
2011-12-29 |
Advanced Bionutrition Corp |
Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
|
|
US9504750B2
(en)
|
2010-01-28 |
2016-11-29 |
Advanced Bionutrition Corporation |
Stabilizing composition for biological materials
|
|
NZ601017A
(en)
*
|
2010-01-28 |
2014-07-25 |
Advanced Bionutrition Corp |
Dry glassy composition comprising a bioactive material
|
|
GB201002419D0
(en)
*
|
2010-02-12 |
2010-03-31 |
Isis Innovation |
Stable live vaccine formulations
|
|
JP5869553B2
(ja)
*
|
2010-03-31 |
2016-02-24 |
スタビリテック リミテッド |
ウイルス粒子、ポリペプチド又は生体材料を安定化させる添加剤
|
|
DK2552410T3
(en)
|
2010-03-31 |
2019-02-18 |
Stabilitech Biopharma Ltd |
PROCEDURE FOR THE CONSERVATION OF ALUNADUVANCES AND VACCINES WITH ALUNADUVANCES
|
|
WO2011121306A1
(en)
*
|
2010-03-31 |
2011-10-06 |
Stabilitech Ltd. |
Stabilisation of viral particles
|
|
CL2011001984A1
(es)
|
2010-08-13 |
2012-06-29 |
Advanced Bionutrition Corp |
Composicion seca estabilizadora para material biologico que comprende carbohidrato, proteinas hidrolizadas de animal o de planta y un componente de acido carboxilico; metodo de preparacion; y formulacion de entrega oral que comprende la composicion seca estabilizadora.
|
|
MX373096B
(es)
|
2010-12-02 |
2020-04-27 |
Oncolytics Biotech Inc |
Formulaciones virales líquidas.
|
|
CA2819236A1
(en)
|
2010-12-02 |
2012-06-07 |
Oncolytics Biotech Inc. |
Lyophilized viral formulations
|
|
GB201117233D0
(en)
|
2011-10-05 |
2011-11-16 |
Stabilitech Ltd |
Stabilisation of polypeptides
|
|
TWI690322B
(zh)
|
2012-10-02 |
2020-04-11 |
法商傳斯堅公司 |
含病毒的調配物及其使用
|
|
GB201406569D0
(en)
|
2014-04-11 |
2014-05-28 |
Stabilitech Ltd |
Vaccine compositions
|
|
DK3552615T3
(da)
|
2014-07-16 |
2022-02-14 |
Transgene |
Onkolytisk virus til ekspression af immun-checkpoint-modulatorer
|
|
CA2975432A1
(en)
|
2015-02-13 |
2016-08-18 |
Transgene Sa |
Immunotherapeutic vaccine and antibody combination therapy
|
|
WO2016131945A1
(en)
|
2015-02-20 |
2016-08-25 |
Transgene Sa |
Combination product with autophagy modulator
|
|
US12558395B2
(en)
|
2015-07-29 |
2026-02-24 |
Advanced Bionutrition Corp. |
Stable dry probiotic compositions for special dietary uses
|
|
EP3328215B1
(en)
|
2015-07-29 |
2021-07-07 |
Advanced BioNutrition Corp. |
Stable dry probiotic compositions for special dietary uses
|
|
US10752876B2
(en)
|
2015-09-02 |
2020-08-25 |
Mcmaster University |
Enhanced thermal stability for adenoviral vectors through spray drying
|
|
CA3023022A1
(en)
|
2016-05-04 |
2017-11-09 |
Transgene Sa |
Combination therapy with cpg tlr9 ligand
|
|
TW201825511A
(zh)
|
2016-09-09 |
2018-07-16 |
美商艾斯合顧問有限公司 |
表現免疫檢查點調節子的溶瘤病毒
|
|
WO2018069316A2
(en)
|
2016-10-10 |
2018-04-19 |
Transgene Sa |
Immunotherapeutic product and mdsc modulator combination therapy
|
|
WO2018091680A1
(en)
|
2016-11-18 |
2018-05-24 |
Transgene Sa |
Cowpox-based oncolytic vectors
|
|
US11626228B2
(en)
*
|
2016-12-22 |
2023-04-11 |
Rogers Corporation |
Multi-layer magneto-dielectric material
|
|
CA3045228C
(en)
|
2016-12-28 |
2024-01-02 |
Transgene Sa |
Oncolytic viruses and therapeutic molecules
|
|
US10617756B2
(en)
|
2017-01-05 |
2020-04-14 |
Shimojani, LLC |
Drug regimen for treatment of cerebral ischemia
|
|
GB2562241B
(en)
|
2017-05-08 |
2022-04-06 |
Stabilitech Biopharma Ltd |
Vaccine compositions
|
|
KR20240113607A
(ko)
|
2017-06-21 |
2024-07-22 |
트랜스진 |
개인 맞춤형 백신
|
|
WO2019020543A1
(en)
|
2017-07-28 |
2019-01-31 |
Transgene Sa |
ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS
|
|
CA3093093A1
(en)
|
2018-03-07 |
2019-09-12 |
Transgene |
Parapoxvirus vectors
|
|
WO2020011754A1
(en)
|
2018-07-09 |
2020-01-16 |
Transgene |
Chimeric vaccinia viruses
|
|
JPWO2020066991A1
(ja)
*
|
2018-09-28 |
2021-08-30 |
株式会社大塚製薬工場 |
アカルボース又はスタキオースを含む哺乳動物細胞保存用液
|
|
EP3875119A4
(en)
|
2018-10-30 |
2022-08-31 |
The University of Tokyo |
ONCOLYTIC VIRUS FOR CANCER THERAPY
|
|
CA3124773A1
(en)
|
2018-12-28 |
2020-07-02 |
Transgene |
M2-defective poxvirus
|
|
WO2020136232A1
(en)
|
2018-12-28 |
2020-07-02 |
Transgene Sa |
Immunosuppressive m2 protein
|
|
CN113613664B
(zh)
|
2019-03-01 |
2025-11-18 |
阿奇洛伊斯生物制药公司 |
在抗原特异性免疫细胞中调节cd160功能的方法及其用途
|
|
CA3171097A1
(en)
*
|
2020-04-14 |
2021-10-21 |
Federico Carlos Arejola Gaeta |
Products and methods for detection of viral nucleic acid
|
|
WO2022011099A1
(en)
*
|
2020-07-08 |
2022-01-13 |
Regents Of The University Of Minnesota |
Modified hexosaminidase and uses thereof
|
|
KR20230038496A
(ko)
|
2020-07-13 |
2023-03-20 |
트랜스진 |
면역 억제의 치료
|
|
CA3207206A1
(en)
|
2021-02-01 |
2022-08-04 |
Lingfeng LIU |
Targeted protein degradation system and use thereof
|
|
WO2022246323A1
(en)
*
|
2021-05-21 |
2022-11-24 |
Takeda Vaccines, Inc. |
Solid composition, freeze-drying method and glass vial
|
|
CN113655057A
(zh)
*
|
2021-08-24 |
2021-11-16 |
威世药业（如皋）有限公司 |
一种检测冷冻干燥处理对痘苗病毒毒力影响的设备
|
|
WO2023025899A2
(en)
|
2021-08-26 |
2023-03-02 |
Transgene |
Delivery system for targeting genes of the interferon pathway
|
|
CN114392237B
(zh)
*
|
2021-12-28 |
2024-02-02 |
上海允英生物医药科技有限公司 |
一种冻干病毒制剂及其制备方法
|
|
WO2023213764A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
|
|
WO2023213763A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
|
|
CN119654339A
(zh)
|
2022-07-01 |
2025-03-18 |
特兰斯吉恩股份有限公司 |
包含表面活性蛋白-d和tnfsf成员的融合蛋白
|
|
KR20250052416A
(ko)
|
2022-08-18 |
2025-04-18 |
트랜스진 |
키메라 폭스바이러스
|
|
WO2026041811A1
(en)
|
2024-08-23 |
2026-02-26 |
Transgene |
Recombinant poxvirus and method for regulating the expression of toxic conditional gene products of said recombinant poxvirus in a producing cell
|